Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia.

about

Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q43570221

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Systematic identification of h ...... acute lymphoblastic leukemia.

@en

Systematic identification of h ...... acute lymphoblastic leukemia.

@nl

type

Item

label

Systematic identification of h ...... acute lymphoblastic leukemia.

@en

Systematic identification of h ...... acute lymphoblastic leukemia.

@nl

prefLabel

Systematic identification of h ...... acute lymphoblastic leukemia.

@en

Systematic identification of h ...... acute lymphoblastic leukemia.

@nl

P1476

Systematic identification of h ...... acute lymphoblastic leukemia.

@en

P2093

Gabriele Stocco

http://www.w3.org/2001/XMLSchema#string

Giuliana Decorti

http://www.w3.org/2001/XMLSchema#string

Margherita Londero

http://www.w3.org/2001/XMLSchema#string

Raffaella Franca

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia

Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype

Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

Concordance of DMET plus genotyping results with those of orthogonal genotyping methods

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

The increasing complexity of mercaptopurine pharmacogenomics.

Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform.

P304

235-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.13.5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23394385

http://www.w3.org/2001/XMLSchema#string